Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
Zydus Lifesciences Ltd
Watchlist
Zydus Lifesciences: High Base to Keep EPS Muted, Specialty Growth Key. Maintain ADD
Equity Bottom-Up
258 Views
11 Nov 2024 17:36
Broker
Zydus Life has corrected over 25% from its 52-week high in the last 2-3 months, due to (1) competition in gAsacol HD (Teva, launched in Sep ’24)
What is covered in the Full Insight:
1. Introduction to Zydus Lifesciences
2. Recent Stock Performance and Challenges
3. Future Growth Prospects and Projections
4. Key Developments in the US and India Markets
5. Conclusion and Investment Insights
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 26-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Event-Driven
Equity Bottom-Up
South Korea
Japan
Podcasts
Equity Capital Markets (ECM)
Equity Derivatives
Asia ECM
India
Trending Insights
More »
CSI 500/1000 Index Rebalance Preview: Strong Near-Term Outperformance
Jiangsu Hengrui Pharma A/H Listing - Low-End Is Probably Close to Fair Value
ChiNext/ChiNext50 Index Rebalance Preview: Whole Lotta Change
Mayne Pharma (MYX AU): Firm Support From Cosette Would Be Welcome About Now
UK: Spurious H1 Surge Again
Top Unpaywalled Insights
More »
AQR DNA in a Digital World: Systematic Edge with Connor Farley - The New Barbarians Episode #019
Curator's Cut: "Bubble" Tea, Japan M&A 🍿and TSMC from Different Lenses
The Coming Global Trade Re-Ordering
The Polycrisis Era (2025–2028): Navigating a World of Overlapping Disruptions
Our AI-Powered Accounting Risk Trading Strategy Beat the S&P 500 by 2.5x
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Zydus Lifesciences: High Base to Keep EPS Muted, Specialty Growth Key. Maintain ADD
11 Nov 2024
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x